Perelman, Moran Gvili
Brzezinski, Rafael Y.
Waissengrin, Barliz
Leshem, Yasmin
Bainhoren, Or
Rubinstein, Tammi Arbel
Perelman, Maxim
Rozenbaum, Zach
Havakuk, Ofer
Topilsky, Yan
Banai, Shmuel
Wolf, Ido
Laufer-Perl, Michal
Article History
Received: 9 August 2023
Accepted: 26 December 2023
First Online: 11 January 2024
Declarations
:
: The study was approved by the Tel Aviv Sourasky Medical Center Helsinki regulatory ethics committee (Identifier: TLV-0228–16)
: Not applicable.
: Michal Laufer-Perl reports grants, consulting fees, and payment of lectures from of lectures from BI and AstraZeneca, and advisory board from BI. The other authors declare no conflict BI and AstraZeneca and advisory board form BI. Ofer Havakuk reports grants, consulting fees, payment of interest.